v3.26.1
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2026
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

During the three months ended June 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted, terminated or modified a Rule 10b5-1 trading arrangement or any “non-Rule 10b5-1 trading agreement” (as defined in Item 408(c) of Regulation S-K), except as set forth below:

 

Name and Position

Action Taken

Type of Plan

Nature of Trading Arrangement

Duration of Trading Arrangement

Aggregate Number of Securities

Paul Peter Tak, M.D., Ph.D., FMedSci (Chief Executive Officer, President and Director)*

Modification (June 11, 2026)

Rule 10b5-1 trading arrangement

Trading plan intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c)

Earlier of (i) June 30, 2027 and (ii) the completed sale of the maximum aggregate number of securities under the plan

Up to 280,245 shares

 

*Plan adopted March 13, 2026.
Paul Peter Tak  
Trading Arrangements, by Individual  
Name Paul Peter Tak
Title Chief Executive Officer, President and Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 11, 2026
Expiration Date June 30, 2027
Aggregate Available 280,245
Rule 10b51 Arr Modified Flag true